open access

Vol 91, No 2 (2020)
Clinical vignette
Published online: 2020-02-12
Get Citation

Unusually high plasma values of many tumour markers in a patient with idiopathic pulmonary fibrosis

Leszek Gottwald12, Mateusz Pajdzinski2, Wojciech J. Piotrowski3, Sebastian Majewski3, Piotr Sieroszewski4, Jacek Fijuth12
·
Pubmed: 32083307
·
Ginekol Pol 2020;91(2):101.
Affiliations
  1. Department of Radiotherapy, Chair of Oncology, Medical University of Lodz, Poland, Poland
  2. Department of Teleradiotherapy, Regional Cancer Centre, Copernicus Memorial Hospital of Lodz, Poland, Poland
  3. Department of Pneumology and Allergy, I Chair of Internal Medicine, Medical University of Lodz, Lodz, Poland
  4. Department of Fetal Medicine and Gynaecology, I Chair of Obstetrics and Gynaecology, Medical University of Lodz, Lodz, Poland

open access

Vol 91, No 2 (2020)
CLINICAL VIGNETTES
Published online: 2020-02-12

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Unusually high plasma values of many tumour markers in a patient with idiopathic pulmonary fibrosis

Journal

Ginekologia Polska

Issue

Vol 91, No 2 (2020)

Article type

Clinical vignette

Pages

101

Published online

2020-02-12

Page views

1517

Article views/downloads

871

DOI

10.5603/GP.a2020.0013

Pubmed

32083307

Bibliographic record

Ginekol Pol 2020;91(2):101.

Authors

Leszek Gottwald
Mateusz Pajdzinski
Wojciech J. Piotrowski
Sebastian Majewski
Piotr Sieroszewski
Jacek Fijuth

References (5)
  1. Martinez FJ, Collard HR, Pardo A, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017; 3: 17074.
  2. Raghu G, Remy-Jardin M, Myers JL, et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198(5): 44–68.
  3. Fujita J, Obayashi Y, Yamadori I, et al. Marked elevation of CA19-9 in a patient with idiopathic pulmonary fibrosis: CA19-9 as a bad prognostic factor. Respirology. 1998; 3(3): 211–214.
  4. Maher TM, Oballa E, Simpson JK, et al. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017; 5(12): 946–955.
  5. Rusanov V, Kramer MR, Raviv Y, et al. The significance of elevated tumor markers among patients with idiopathic pulmonary fibrosis before and after lung transplantation. Chest. 2012; 141(4): 1047–1054.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl